Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & working
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Precision medicine industry 3600 synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Product type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Precision Medicine Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Advancements in cancer biology in developed region
3.3.1.2 Expanding portfolio of precision medicine drugs
3.3.1.3 Rise in online collaborative forums
3.3.1.4 Increasing adoption of gene therapy in Asia Pacific
3.3.2 Industry pitfalls and challenges
3.3.2.1 High cost of precision medicines
3.3.2.2 Violation of privacy rule and potential threat to personal health data
3.3.2.3 Stringent regulatory norms
3.4 Growth potential analysis
3.4.1 By product type
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2020
3.8 PESTEL analysis
Chapter 4 Precision Medicine Market, By Product Type
4.1 Key segment trends
4.2 Diagnostics
4.2.1 Market size, by region, 2016-2027 (USD Million)
4.2.2 Genetic tests
4.2.2.1 Market size, by region, 2016-2027 (USD Million)
4.2.3 Biomarker based tests
4.2.3.1 Market size, by region, 2016-2027 (USD Million)
4.2.4 Others
4.2.4.1 Market size, by region, 2016-2027 (USD Million)
4.3 Therapeutics
4.3.1 Market size, by region, 2016-2027 (USD Million)
Chapter 5 Precision Medicine Market, By Application
5.1 Key segment trends
5.2 Oncology
5.2.1 Market size, by region, 2016-2027 (USD Million)
5.3 CNS
5.3.1 Market size, by region, 2016-2027 (USD Million)
5.4 Immunology
5.4.1 Market size, by region, 2016-2027 (USD Million)
5.5 Respiratory
5.5.1 Market size, by region, 2016-2027 (USD Million)
5.6 Others
5.6.1 Market size, by region, 2016-2027 (USD Million)
Chapter 6 Precision Medicine Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, by region, 2016-2027 (USD Million)
6.3 Diagnostic centers
6.3.1 Market size, by region, 2016-2027 (USD Million)
6.4 Research & academic institutes
6.4.1 Market size, by region, 2016-2027 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2016-2027 (USD Million)
Chapter 7 Precision Medicine Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2016-2027 (USD Million)
7.2.2 Market size, by product type, 2016-2027 (USD Million)
7.2.2.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.2.3 Market size, by application, 2016-2027 (USD Million)
7.2.4 Market size, by end-use, 2016-2027 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by product type, 2016-2027 (USD Million)
7.2.5.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.2.5.2 Market size, by application, 2016-2027 (USD Million)
7.2.5.3 Market size, by end-use, 2016-2027 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by product type, 2016-2027 (USD Million)
7.2.6.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.2.6.2 Market size, by application, 2016-2027 (USD Million)
7.2.6.3 Market size, by end-use, 2016-2027 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2016-2027 (USD Million)
7.3.2 Market size, by product type, 2016-2027 (USD Million)
7.3.2.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.3.3 Market size, by application, 2016-2027 (USD Million)
7.3.4 Market size, by end-use, 2016-2027 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by product type, 2016-2027 (USD Million)
7.3.5.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.3.5.2 Market size, by application, 2016-2027 (USD Million)
7.3.5.3 Market size, by end-use, 2016-2027 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by product type, 2016-2027 (USD Million)
7.3.6.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.3.6.2 Market size, by application, 2016-2027 (USD Million)
7.3.6.3 Market size, by end-use, 2016-2027 (USD Million)
7.3.7 France
7.3.7.1 Market size, by product type, 2016-2027 (USD Million)
7.3.7.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.3.7.2 Market size, by application, 2016-2027 (USD Million)
7.3.7.3 Market size, by end-use, 2016-2027 (USD Million)
7.3.8 Italy
7.3.8.1 Market size, by product type, 2016-2027 (USD Million)
7.3.8.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.3.8.2 Market size, by application, 2016-2027 (USD Million)
7.3.8.3 Market size, by end-use, 2016-2027 (USD Million)
7.3.9 Spain
7.3.9.1 Market size, by product type, 2016-2027 (USD Million)
7.3.9.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.3.9.2 Market size, by application, 2016-2027 (USD Million)
7.3.9.3 Market size, by end-use, 2016-2027 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2016-2027 (USD Million)
7.4.2 Market size, by product type, 2016-2027 (USD Million)
7.4.2.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.4.3 Market size, by application, 2016-2027 (USD Million)
7.4.4 Market size, by end-use, 2016-2027 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by product type, 2016-2027 (USD Million)
7.4.5.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.4.5.2 Market size, by application, 2016-2027 (USD Million)
7.4.5.3 Market size, by end-use, 2016-2027 (USD Million)
7.4.6 China
7.4.6.1 Market size, by product type, 2016-2027 (USD Million)
7.4.6.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.4.6.2 Market size, by application, 2016-2027 (USD Million)
7.4.6.3 Market size, by end-use, 2016-2027 (USD Million)
7.4.7 India
7.4.7.1 Market size, by product type, 2016-2027 (USD Million)
7.4.7.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.4.7.2 Market size, by application, 2016-2027 (USD Million)
7.4.7.3 Market size, by end-use, 2016-2027 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by product type, 2016-2027 (USD Million)
7.4.8.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.4.8.2 Market size, by application, 2016-2027 (USD Million)
7.4.8.3 Market size, by end-use, 2016-2027 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size, by product type, 2016-2027 (USD Million)
7.4.9.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.4.9.2 Market size, by application, 2016-2027 (USD Million)
7.4.9.3 Market size, by end-use, 2016-2027 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2016-2027 (USD Million)
7.5.2 Market size, by product type, 2016-2027 (USD Million)
7.5.2.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.5.3 Market size, by application, 2016-2027 (USD Million)
7.5.4 Market size, by end-use, 2016-2027 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by product type, 2016-2027 (USD Million)
7.5.5.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.5.5.2 Market size, by application, 2016-2027 (USD Million)
7.5.5.3 Market size, by end-use, 2016-2027 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by product type, 2016-2027 (USD Million)
7.5.6.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.5.6.2 Market size, by application, 2016-2027 (USD Million)
7.5.6.3 Market size, by end-use, 2016-2027 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size, by product type, 2016-2027 (USD Million)
7.5.7.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.5.7.2 Market size, by application, 2016-2027 (USD Million)
7.5.7.3 Market size, by end-use, 2016-2027 (USD Million)
7.6 Middle East and Africa
7.6.1 Market size, by country, 2016-2027 (USD Million)
7.6.2 Market size, by product type, 2016-2027 (USD Million)
7.6.2.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.6.3 Market size, by application, 2016-2027 (USD Million)
7.6.4 Market size, by end-use, 2016-2027 (USD Million)
7.6.5 Saudi Arabia
7.6.5.1 Market size, by product type, 2016-2027 (USD Million)
7.6.5.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.6.5.2 Market size, by application, 2016-2027 (USD Million)
7.6.5.3 Market size, by end-use, 2016-2027 (USD Million)
7.6.6 UAE
7.6.6.1 Market size, by product type, 2016-2027 (USD Million)
7.6.6.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.6.6.2 Market size, by application, 2016-2027 (USD Million)
7.6.6.3 Market size, by end-use, 2016-2027 (USD Million)
7.6.7 South Africa
7.6.7.1 Market size, by product type, 2016-2027 (USD Million)
7.6.7.1.1 Market size, by diagnostics, 2016-2027 (USD Million)
7.6.7.2 Market size, by application, 2016-2027 (USD Million)
7.6.7.3 Market size, by end-use, 2016-2027 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2020
8.2 Pfizer Inc
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Qiagen Inc
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Quest Diagnostics Inc
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Medtronic
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Novartis AG
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Laboratory Corporation of America Holdings
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 bioMérieux SA
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Abbott Laboratories
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 F Hoffmann-La Roche AG
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Eli Lilly & Company
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 Glaxosmithkline Plc
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Cepheid Inc
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 AstraZeneca plc
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Product landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
8.15 Cancer Genetics Inc
8.15.1 Business overview
8.15.2 Financial data
8.15.3 Product landscape
8.15.4 Strategic outlook
8.15.5 SWOT analysis
8.16 Thermo Fisher Scientific Inc
8.16.1 Business overview
8.16.2 Financial data
8.16.3 Product landscape
8.16.4 Strategic outlook
8.16.5 SWOT analysis
8.17 Bristol-Myers Squibb
8.17.1 Business overview
8.17.2 Financial data
8.17.3 Product landscape
8.17.4 Strategic outlook
8.17.5 SWOT analysis
8.18 Myriad Genetics Inc
8.18.1 Business overview
8.18.2 Financial data
8.18.3 Product landscape
8.18.4 Strategic outlook
8.18.5 SWOT analysis
8.19 Foundation Medicine
8.19.1 Business overview
8.19.2 Financial data
8.19.3 Product landscape
8.19.4 Strategic outlook
8.19.5 SWOT analysis
